thalidomide has been researched along with Eosinophilia, Tropical in 5 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eosinophilia has rarely been described with lenalidomide." | 7.88 | Eosinophilia secondary to lenalidomide therapy. ( Collado-Borrell, R; Escudero-Vilaplana, V; González-Arias, E; Osorio-Prendes, S; Sanjurjo-Sáez, M, 2018) |
| "To evaluate the curative effect of albendazole/thalidomide co-therapy on eosinophilic meningitis in BALB/c mice caused by Angiostrongylus cantonensis." | 7.74 | Biochemical and pathological evaluation of albendazole/thalidomide co-therapy against eosinophilic meningitis or meningoencephalitis induced by Angiostrongylus cantonensis. ( Chen, KM; Lai, SC, 2007) |
| "Eosinophilia has rarely been described with lenalidomide." | 3.88 | Eosinophilia secondary to lenalidomide therapy. ( Collado-Borrell, R; Escudero-Vilaplana, V; González-Arias, E; Osorio-Prendes, S; Sanjurjo-Sáez, M, 2018) |
| "To evaluate the curative effect of albendazole/thalidomide co-therapy on eosinophilic meningitis in BALB/c mice caused by Angiostrongylus cantonensis." | 3.74 | Biochemical and pathological evaluation of albendazole/thalidomide co-therapy against eosinophilic meningitis or meningoencephalitis induced by Angiostrongylus cantonensis. ( Chen, KM; Lai, SC, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Escudero-Vilaplana, V | 1 |
| Osorio-Prendes, S | 1 |
| Collado-Borrell, R | 1 |
| González-Arias, E | 1 |
| Sanjurjo-Sáez, M | 1 |
| Kottler, D | 1 |
| Barète, S | 1 |
| Quéreux, G | 1 |
| Ingen-Housz-Oro, S | 1 |
| Fraitag, S | 1 |
| Ortonne, N | 1 |
| Deschamps, L | 1 |
| Rybojad, M | 1 |
| Flageul, B | 1 |
| Crickx, B | 1 |
| Janin, A | 1 |
| Bagot, M | 1 |
| Battistella, M | 1 |
| Mehta, AA | 1 |
| Venkatakrishnan, R | 1 |
| Jose, W | 1 |
| Palaniappan, M | 1 |
| Pavithran, K | 1 |
| Chen, KM | 1 |
| Lai, SC | 1 |
| Bielsa, I | 1 |
| Teixidó, J | 1 |
| Ribera, M | 1 |
| Ferrándiz, C | 1 |
5 other studies available for thalidomide and Eosinophilia, Tropical
| Article | Year |
|---|---|
Eosinophilia secondary to lenalidomide therapy.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Hormonal; Cyclophosphamide; Dexamethasone; Eosinophi | 2018 |
Retrospective Multicentric Study of 25 Kimura Disease Patients: Emphasis on Therapeutics and Shared Features with Cutaneous IgG4-Related Disease.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Angiolymphoid Hyperplasia with | 2015 |
Multiple myeloma presenting as eosinophilic pleural effusion.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Diagnosis, Differential; Eosino | 2010 |
Biochemical and pathological evaluation of albendazole/thalidomide co-therapy against eosinophilic meningitis or meningoencephalitis induced by Angiostrongylus cantonensis.
Topics: Albendazole; Angiostrongylus cantonensis; Animals; Antinematodal Agents; Brain; Disease Models, Anim | 2007 |
Erythroderma due to thalidomide: report of two cases.
Topics: Adult; Dermatitis, Exfoliative; Drug Eruptions; Eosinophilia; Female; Humans; Kidney Failure, Chroni | 1994 |